The official said the DPA has not caused the global shortages of vaccine materials, and the problems stem instead from overwhelming demand. Reuters could not determine precisely what share of vaccine materials and equipment are made in America. After weeks of public appeals from the Serum, the United States last month offered India filters needed to produce COVISHIELD. Serum, which declined to discuss the raw materials issue with Reuters, is not the only vaccine maker in need. Cytiva said in a statement that it is expanding production, but is itself limited by some raw materials shortages.

Source: bd News24 May 08, 2021 02:26 UTC